About
UNDBIO is a pharmaceutical company that handles insulin, insulin analogues, monoclonal antibodies, general injectables, and related medical device products. Its headquarters are in Uijeongbu-si, Gyeonggi-do, and its research institute is in Suwon-si, Gyeonggi-do.
Undbio is a CDMO in Gyeonggi, South Korea. It lists 2 services, including Drug Device Combination and Monoclonal antibody (mAb).
Services
Drug Device Combination
It carries out co-package development with medical device products such as insulin pumps and continuous glucose monitoring systems.
Monoclonal antibody (mAb)
It handles monoclonal antibody products such as adalimumab and bevacizumab.
How to order from Undbio
They take requests through the contact form on their website. You can contact them directly from this page, or request a quote through Midgard.
Capabilities
- Assays and studies
- Efficacy research
- Analytical method development
- Quality control testing
- Quality assurance management
- Therapeutic areas
- Diabetes
- Cancer
- Immune-related intractable diseases
- Anticancer drugs
- Genetic rare diseases
Modalities and species
- Modalities
- Antibody
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: global GMP-certified pharmaceutical facilities
Company
- Type
- CDMO
- Quality
- 글로벌 GMP (Maintenance and management of the quality management system) · GMP (global GMP-certified pharmaceutical facilities)
Locations
- Based in
- Gyeonggi, South Korea
- Sites
- 의정부시, 대한민국
- 수원시, 대한민국
- Serves
- Domestic, Overseas, All low-development countries worldwide
Contacts
- Phone
- 031-853-6409